» Articles » PMID: 19632065

Functional Interference Clusters in Cancer Patients with Bone Metastases: a Secondary Analysis of RTOG 9714

Overview
Specialties Oncology
Radiology
Date 2009 Jul 28
PMID 19632065
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To explore the relationships (clusters) among the functional interference items in the Brief Pain Inventory (BPI) in patients with bone metastases.

Methods: Patients enrolled in the Radiation Therapy Oncology Group (RTOG) 9714 bone metastases study were eligible. Patients were assessed at baseline and 4, 8, and 12 weeks after randomization for the palliative radiotherapy with the BPI, which consists of seven functional items: general activity, mood, walking ability, normal work, relations with others, sleep, and enjoyment of life. Principal component analysis with varimax rotation was used to determine the clusters between the functional items at baseline and the follow-up. Cronbach's alpha was used to determine the consistency and reliability of each cluster at baseline and follow-up.

Results: There were 448 male and 461 female patients, with a median age of 67 years. There were two functional interference clusters at baseline, which accounted for 71% of the total variance. The first cluster (physical interference) included normal work and walking ability, which accounted for 58% of the total variance. The second cluster (psychosocial interference) included relations with others and sleep, which accounted for 13% of the total variance. The Cronbach's alpha statistics were 0.83 and 0.80, respectively. The functional clusters changed at week 12 in responders but persisted through week 12 in nonresponders.

Conclusion: Palliative radiotherapy is effective in reducing bone pain. Functional interference component clusters exist in patients treated for bone metastases. These clusters changed over time in this study, possibly attributable to treatment. Further research is needed to examine these effects.

Citing Articles

Utilization Patterns of Single-Fraction and Short-Course Radiotherapeutic Schedules in the Management of Bone Metastases.

Koduri S, Abel S, Bergin J, Fuhrer R, Beriwal S, Wegner R Adv Radiat Oncol. 2023; 8(3):101176.

PMID: 36846440 PMC: 9946850. DOI: 10.1016/j.adro.2023.101176.


Factors Affecting the Quality of Life of Patients with Painful Spinal Bone Metastases.

Akezaki Y, Nakata E, Kikuuchi M, Sugihara S, Katayama Y, Katayama H Healthcare (Basel). 2021; 9(11).

PMID: 34828545 PMC: 8625781. DOI: 10.3390/healthcare9111499.


A randomized trial of conventional fraction versus hypofraction radiotherapy for bone metastases from hepatocellular carcinoma.

He J, Shi S, Ye L, Ma G, Pan X, Huang Y J Cancer. 2019; 10(17):4031-4037.

PMID: 31417647 PMC: 6692619. DOI: 10.7150/jca.28674.


Evaluation of Quality of Life Using EORTC QLQ-BM22 in Patients with Bone Metastases after Treatment with Magnetic Resonance Guided Focused Ultrasound.

Chen Z, Wang C, Ma X, Sun W, Shen J, Sun M Orthop Surg. 2018; 10(3):264-271.

PMID: 30019516 PMC: 6594524. DOI: 10.1111/os.12383.


Quality of life after palliative radiotherapy in bone metastases: A literature review.

McDonald R, Chow E, Rowbottom L, Bedard G, Lam H, Wong E J Bone Oncol. 2015; 4(1):24-31.

PMID: 26579481 PMC: 4620945. DOI: 10.1016/j.jbo.2014.11.001.


References
1.
Hartsell W, Scott C, Bruner D, Scarantino C, Ivker R, Roach 3rd M . Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005; 97(11):798-804. DOI: 10.1093/jnci/dji139. View

2.
Saxena A, Mendoza T, Cleeland C . The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage. 1999; 17(1):27-41. DOI: 10.1016/s0885-3924(98)00104-3. View

3.
Beck S, Dudley W, Barsevick A . Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum. 2005; 32(3):542. DOI: 10.1188/04.ONF.E48-E55. View

4.
Cleeland C, Nakamura Y, Mendoza T, Edwards K, Douglas J, Serlin R . Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996; 67(2-3):267-73. DOI: 10.1016/0304-3959(96)03131-4. View

5.
Barsevick A, Dudley W, Beck S . Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res. 2006; 55(5):366-72. DOI: 10.1097/00006199-200609000-00009. View